INDEX 1 1Q FY03/27 Results Overview 2 Progress of Priority Measures 3 APPENDIX 1 1Q FY03/27 Results Overview 1. Overall Summary (Recurring Revenue and Recurring Profit) 2. Income Statement Summary 3. Recurring Expenses and Profit Indicators 4.…
INDEX
1
1Q FY03/27 Results Overview
2
Progress of Priority Measures
3
APPENDIX
1
1Q FY03/27 Results Overview
1.
Overall Summary (Recurring Revenue and Recurring Profit)
2.
Income Statement Summary
3.
Recurring Expenses and Profit Indicators
4.
Factors behind Changes in Recurring Profit (YoY Analysis)
5.
Balance Sheet Summary
- Overall Summary (Recurring Revenue and Recurring Profit)
Recurring revenue
Recurring profit
before amortization
of goodwill
Recurring profit
Results
Overview
Priority
Measures
APPENDIX
21,403 Million JPY
+17.4% YoY (+JPY 3,167 mn)
Of which, underwriting revenue: +5.9% YoY (+JPY 936 mn)
3,594 Million JPY
+250.5% YoY (+JPY 2,569 mn)
3,530 Million JPY
+267.5% YoY (+JPY 2,569 mn)
Steady acquisition of new policies, expansion of ancillary businesses, and increased
investment revenue drove higher revenue and profit.
Both recurring revenue and recurring profit reached record highs for a first quarter.
◼ Recurring revenue
➢ The number of new pet insurance policies was 60,000, while the number of policies in force reached 1,411,000 (+7.1%), continuing to grow
➢ Outside the insurance business, other recurring revenue grew steadily to JPY 2,436 million (+16.3%)
➢ Investment revenue was JPY2,252 million ( +521.8% ), progressing in line with the plan (see page 12 for details).
◼ Recurring profit
➢ Profit increased significantly due to the absence of costs associated with the transfer of AXA Direct policies and an increase in investment
revenue. Progress is also on track to achieve the plan.
Copyright © Anicom Holdings, Inc. All Rights Reserved
4
- Overall Summary (Recurring Revenue and Recurring Profit)
Results
Overview
Priority
Measures
APPENDIX
(Reference) FY03/27 Earnings Forecast (Full Year and Cumulative First Half)
Cumulative First-Half Plan
Full-Year Plan
5,000
4,941
(Up 41.1% YoY)
Recurring
経常利益
revenue
(百万円)
Recurring profit
(JPY mn)
3,543
4,000
81,000
(JPY mn)
81,000
(Up 9.7% YoY)
Recurring
profit
経常収益
(百万円)
(JPY
mn)
5,000
73,846
Recurring revenue
67,683
(JPY mn)
41,000
FY03/25 Results
25年3月期実績
FY03/26 Results
26年3月期実績
FY03/27 Plan
27年3月期計画
Copyright © Anicom Holdings, Inc. All Rights Reserved
2Q
4Q
5
Results
Overview
- Income Statement Summary
Priority
Measures
APPENDIX
(JPYmn)
1Q
FY03/26
Recurring revenue
Underw riting revenue
Investm ent revenue
Other recurring revenue
Recurring expenses
Underw riting expenses
・Net claims paid
・Loss adjustment expenses
・Net commission and collection expenses
・Provision for loss reserves
・Provision for underw riting reserves
Of w hich unearned premiums
Of w hich catastrophe reserve
Investm ent expenses
Operating and general adm inistrative expenses
Other recurring expenses
Recurring profit before amortization of goodwill
Recurring profit
Net profit
1Q
FY03/27
Change
18,235
21,403
15,778
362
2,095
16,714
2,252
2,436
17,275
17,873
11,298
11,561
2.3
%
(8,759)
(9,954)
13.6
%
(290)
(344)
18.6
%
(1,412)
(1,534)
8.7
%
(396)
(230)
-42.0
%
(439)
(-502)
ー
%
(711)
(466)
-34.5
%
(-272)
(-968)
ー
%
1
310
ー
%
5,224
5,146
-1.5
%
750
855
14.0
%
1,025
960
650
3,594
3,530
2,433
17.4 %
5.9
521.8
16.3
%
%
%
3.5 %
250.5 %
267.5 %
274.0 %
- Under the financial statement format prescribed by the Ordinance for Enforcement of the Insurance Business Act, when the provision for underwriting reserves is negative, it must be presented within consolidated
recurring revenue as a reversal for underwriting reserves.
However, in these supplementary explanatory materials, it is presented as a component of underwriting expenses to facilitate comparison with prior periods.
Consequently, there is a difference of JPY 502 million from the consolidated recurring revenue of JPY 21,905 million disclosed in the financial results. This difference has no impact on consolidated recurring profit.
Copyright © Anicom Holdings, Inc. All Rights Reserved
6
Results
Overview
- Income Statement Summary
Priority
Measures
APPENDIX
(Reference) Anicom Insurance’s key insurance indicators
(JPYmn)
1Q
FY03/26
Earned prem ium s
1Q
FY03/27
Change
15,134
16,313
7.8%
Claim s incurred (including loss adjustm ent expenses)
9,446
10,528
11.5%
E/I loss ratio (1)
62.4%
64.5%
2.1pt
Expense ratio (based on earned prem ium s) (2)
35.5%
31.0%
-4.5pt
(9.8%)
(9.9%)
(0.1pt)
97.9%
95.5%
-2.4pt
(of w hich, net com m ission and collection expense ratio)
Com bined ratio (based on earned prem ium s) (1)+(2)
Copyright © Anicom Holdings, Inc. All Rights Reserved
7
Results
Overview
- Recurring Expenses and Profit Indicators
Priority
Measures
APPENDIX
- Operating and general administrative expenses ratio, recurring profit ratio (consolidated)
*Refer to the appendix for management parameters for Anicom Insurance on a nonconsolidated basis (loss ratio, expense ratio, number of policies)
40
Consolidated operating and general administrative expenses ratio
連結販管費率
(%)
Product
revisions Consolidated recurring profit ratio
連結経常利益率
30
28.7
27.6
27.2
27.6
26.3
26.4
26.5
26.1
25.6
25.3
26.2
26.9
28.8
28.6
27.0
26.2
24.0
Transfer of AXA
DIRECT insurance policies
20
16.5
10
9.8
8.1
8.4
5.6
9.2
9.4
7.0
6.8
6.4
5.3
4.4
5.7
3Q
4Q
5.3
6.3
1Q
2Q
0.7
3.9
0
1Q
2Q
3Q
23年3月期
FY03/23
4Q
1Q
2Q
24年3月期
FY03/24
1Q
2Q
3Q
25年3月期
FY03/25
Copyright © Anicom Holdings, Inc. All Rights Reserved
4Q
3Q
26年3月期
FY03/26
4Q
1Q
27年
FY03
3月期
/27
8
- Factors behind Changes in Recurring Profit (YoY Analysis)
Results
Overview
Priority
Measures
APPENDIX
Note 1) Earned premiums = Underwriting revenue - Provision for normal underwriting reserves (Unearned premiums)
Note 2) Claims incurred = Net claims paid + Provision for loss reserves
Note 3) Catastrophe reserve = Provision for catastrophe reserve losses and claims + Reversal of catastrophe reserve reimbursements
(JPY mn)
Investment
revenue
Earned
premiums
Claims
incurred
※1
※2
+1,181
Agency
Catastrophe
commissions reserve
Investment
expenses
Other
recurring
revenue
-308
+340
Operating and
Other
general
recurring administrative
expenses
expenses
-105
+24
+1,890
※3
3,530
-1,027
+696
-122
960
1Q FY03/26 Results
Consolidated recurring profit
1Q FY03/27 Results
Consolidated recurring profit
Copyright © Anicom Holdings, Inc. All Rights Reserved
9
Results
Overview
- Balance Sheet Summary
Priority
Measures
APPENDIX
(JPY mn)
End- FY03/26
Total assets
1Q
FY03/27
Change
76,693
75,738
-1.2 %
13,392
42,631
10,077
10,592
10,588
43,321
10,690
11,137
-20.9 %
1.6 %
6.1 %
5.1 %
47,751
46,477
-2.7 %
28,808
4,346
-0.9 %
Of which loss reserves
29,080
4,116
Of which underwriting reserves
24,964
24,461
-2.0 %
Bonds payable
5,000
5,000
ー %
Other liabilities
13,670
12,669
-7.3 %
5,105
5,103
-0.0 %
28,942
29,261
1.1 %
30,700
-1608
31,984
-2573
4.2 %
ー %
-149
-149
ー %
76,693
75,738
-1.2 %
Cash and deposits
Securities
Fixed assets
Other assets
Total liabilities
Reserve for insurance policy liabilities
Of which,borrowings
Total net assets
Shareholders' equity
Valuation difference on available-for-salesecurities
Other
Total liabilities and net assets
Copyright © Anicom Holdings, Inc. All Rights Reserved
5.6 %
10
2
Progress of Priority Measures
1.
Progress of Priority Measures
2.
Progress of Priority Measures
3.
Topics
(Insurance Business, Investment, Other)
(Businesses Generating Synergies)
Results
Overview
- Progress of Priority Measures (Insurance Business, Investment, Other)
Insurance
Business
Priority
Measures
APPENDIX
Status of new policies and
policies in force
➢ The number of new policies remained high at 60,000 for the quarter.
Expansion of Products and
Services
➢ Owing to initiatives such as Doubutsu Kenkatsu, the renewal rate remained stable and high at
Diverse Sales
Channels
➢ The number of policies in force exceeded 1.41 million as of June 30, 2026.
88.3%.
➢ Expanding white-label initiatives (OEM) with domestic life and non-life insurers, with
eight partner companies
➢ Steadily accumulated income gains while capitalizing on improved market environment to realize gains on
the sale of equities.
➢ In light of the market environment, determined that this was an opportune time to review the allocation of
invested assets and enhance portfolio profitability and capital efficiency.
Investment
➢ Going forward, we will continue to closely monitor market conditions, appropriately capture capital returns,
Efficient Investment
replace low-yielding assets and assets with unrealized losses, with the aim of stabilizing investment
Management in Response to and
revenue over the medium to long term and improving capital efficiency.
Changing Market
Environment
Promotion of “One Patent per Employee” Strategy As of June 30, 2026: 163 inventors
[Number of Patents by Field] *As of June 30, 2026 (Examples are provided on page 18)
Other
Patents
granted
Image Recognition
AI
Genetics, Food &
Gut Microbiota
Regenerative
Medicine
Other
Total
12
12
2
4
30
Copyright © Anicom Holdings, Inc. All Rights Reserved
12
Results
Overview
- Progress of Priority Measures (Businesses Generating Synergies 1)
Before birth
Upstream
Strengthening Breeding Support
Considering a framework to support compliance
with the Act on Welfare and Management of
Animals and breeding operations
Priority
Measures
Day-to-day routines
Curing the incurable
Midstream
Downs
tream
Health checkups + expansion of oral
and intestinal care products
APPENDIX
Business related to animal healthcare
treatments
(from prevention to general practice and advanced medical care)
Held tasting sessions and seminars for
various care products through Doubutsu
Kenkatsu at locations nationwide
Firmly established in the local community, with
the number of consultations remaining steady
Health Innovation Business results for 1Q FY03/27
JPY 171 million
Animal Hospital Operations Business results
for 1Q FY03/27
JPY 820 million
JARVIS Animal Medical Center Tokyo
Strengthening the Matching Service Business
“Minna no Breeder” and “Minna no Koneko Breeder”
Cumulative transactions for dogs and cats exceeded
460,000
Matching Service Business results for 1Q FY03/27
JPY 580 million
Net sales:
(Previous year: JPY 596 million)
Recurring profit:
JPY 46 million
Net sales:
Recurring profit:
(Previous year: JPY 84 million)
Note: Net sales are external sales; recurring profit is after goodwill amortization.
Advertising revenue decreased.Although average
transaction value increased slightly, the number of
completed transactions remained broadly flat. Efforts are
focused on improving matching efficiency and developing
offline customer acquisition channels.
(Previous year: JPY 124 million)
JPY -74 million
(Previous year: JPY -61 million)
Note: Net sales are external sales.
Sales expanded as the e-commerce channel steadily
acquired subscription customers. Efforts are also
underway to improve efficiency by focusing on core
products and controlling promotional expenses.
Copyright © Anicom Holdings, Inc. All Rights Reserved
Net sales:
Recurring profit:
(Previous year: JPY 682 million)
JPY -191 million
(Previous year: JPY 60 million)
Note: Net sales are external sales; recurring profit is after goodwill amortization.
Sales increased significantly due to JARVIS Tokyo, while
an existing hospital was closed and another scaled back
its operations. Progress remains in line with the plan.
13
Results
Overview
- Progress of Priority Measures (Businesses Generating Synergies 2)
Priority
Measures
APPENDIX
● Key KPIs for the Animal Hospital Operations Business
“JARVIS Animal Medical Center Tokyo” drove earnings growth, with sales reaching 120% of the previous year’s level.
Further growth is expected from an increase in cases and the capture of demand for advanced medical care.
(JPY
mn)
(百万円)
SalesTrends
As of 1Q
1Q時点
3,900
~
3,700
Full year
通期
2,401
2,170
1,875
820
553
682
651
Progress rate: 22% ※1
YoY comparison: 120%
2024年3月期
FY03/24
2025年3月期
FY03/25
2026年3月期
FY03/26
2027年3月期
FY03/27
- Calculated based on a full-year revenue forecast of JPY 3,800 million
Copyright © Anicom Holdings, Inc. All Rights Reserved
14
Results
Overview
- Progress of Priority Measures (Businesses Generating Synergies 3)
Priority
Measures
APPENDIX
● JARVIS Animal Medical Center Tokyo
Although sales are behind plan, they continue to maintain a steady growth trend.
Sales of approximately JPY 80 million are projected for July.
(百万円)
(JPY
mn)
JARVIS Animal Medical Center Tokyo
Monthly Sales Trends
98
89
80
77
Forecast
67
58
60
61
5月
May
6月
June
66
46
39
50
34
43
31
15
Result
Plan
23
6
10
2
10月
October
11月
November
12月
December
3Q
1月
January
2月
February
3月
March
4月
April
4Q
FY03/26
2026年3月期
1Q
7月
July
2Q
FY03/27
2027年3月期
Copyright © Anicom Holdings, Inc. All Rights Reserved
15
- Topics (1): Analysis and Awareness-Raising as a “Preventive Insurance Company”
Results
Overview
Priority
Measures
APPENDIX
Launch of “Weekly Heatstroke Forecast” for Dogs and Cats
Analysis of Accidental Ingestion among Dogs and Cats
In 2026, we once again began distributing our “Weekly Heatstroke
Forecast” through social media and other channels. This initiative
has continued since 2013 for dogs and 2022 for cats, and aims to
prevent heatstroke—a preventable condition—by helping owners
take appropriate precautions. We also published the results of our
analysis of insurance claims data, which revealed that the risk of
heatstroke tends to be higher among households that have
welcomed a dog or cat for the first time and animals that experienced
heatstroke in the previous year.
We analyzed accidental ingestion among dogs and cats based on
insurance claims data. The results showed that such incidents are
most common among dogs and cats aged zero to two. The risk also
tends to be particularly high among households that have welcomed
a dog or cat for the first time and animals with a history of accidental
ingestion. We are raising awareness that owners can help prevent
these incidents by creating a safe living environment and ensuring
that their dogs and cats get sufficient daily exercise.
Press release issued April 24, 2026 (In Japanese only):
https://www.anicom-sompo.co.jp/news-release/2026/20260424/
Press release issued May 28, 2026 (In Japanese only):
https://www.anicom-sompo.co.jp/news-release/2026/20260528/
Copyright © Anicom Holdings, Inc. All Rights Reserved
16
- Topics (2): Health Care for Realizing Preventive Insurance
Results
Overview
Priority
Measures
APPENDIX
Planned Launch of “7Days Food Puree” Treats for Dogs
The Anicom Group plans to launch “7Days Food Puree,” a new series
under its food brand, jointly developed with ARIAKE JAPAN Co., Ltd.
Combining the Anicom Group’s health expertise with Ariake Japan’s food
technology,
the companies have developed a savory bouillon-based dog treat that
brings out the natural flavor of each ingredient. The product comes in
easy-to-use stick packs that can be added to daily meals and allows
owners to rotate among seven different protein sources. By providing a
tasty, different source of protein each day, it helps support a healthy daily
diet for dogs.
Press release issued August 7, 2026 (In Japanese only):
https://www.anicom-pafe.com/tands/tands_20260807.html
- This product is currently under development; its specifications, design, and other details are subject to change.
“Health Expertise”
“Food Technology”
・Leveraging health expertise accumulated
through both insurance and preventive care to
support animals’ immune health through food
・A cross-Group service platform that supports
every aspect of animals’ lives
・Natural stock extraction technology refined over 60
years
・Product development and flavor formulation expertise
that brings out the deliciousness of natural ingredients
・An integrated production and quality-control system
based on FSSC and HACCP standards
Plans to launch a new series that creates value at the intersection of food and health, supporting
the healthy lives of beloved dogs and cats
Copyright © Anicom Holdings, Inc. All Rights Reserved
17
Results
Overview
- Topics (3): Initiatives to Enrich Life with Animals
Priority
Measures
APPENDIX
Patent Obtained for an “Animal Rearing Method”
11th “Doubutsu Senryu” Contest Held
Anicom and DENBA JAPAN Co., Ltd. jointly obtained a patent for
an “animal rearing method.” The patented method applies DENBA
JAPAN’s electric potential technology to animal rearing
environments. The resulting findings demonstrate new
possibilities for such environments and are expected to
contribute to further research.
The “Doubutsu Senryu” contest, which annually attracts poems filled with
affection for animals, was held again in 2026. Beginning this year, entries
could be submitted through social media in addition to the conventional
dedicated entry form, resulting in a large number of submissions.
Press release issued April 17, 2026 (In Japanese only):
https://www.anicom.co.jp/news-release/2026/20260417/
Press release issued June 1, 2026 (In Japanese only):
https://www.anicom-sompo.co.jp/news-release/2026/20260601
Copyright © Anicom Holdings, Inc. All Rights Reserved
18
Results
Overview
- Topics (4): Research Achievements
Genome Sequencing of Wild Ezo Deer in Hokkaido
Anicom Specialty Medical Institute, Inc., in collaboration with the Forestry and
Forest Products Research Institute of the Forest Research and Management
Organization and Azabu University, published high-quality genomic data for wild
Ezo deer in Hokkaido. This provides a research foundation for studying their
evolution, genetic diversity, and ecology, as well as for managing the species as
a resource.
Priority
Measures
APPENDIX
Age- and Breed-Related Differences in Periodontal
Disease Risk Identified
An analysis of insurance claims data revealed that the risk of periodontal
disease in dogs and cats varies not only with age but also by breed,
demonstrating the importance of prevention and care from an early age.
Press release issued May 12, 2026 (In Japanese only):
https://www.anicom-sompo.co.jp/news-release/2026/20260512/
Press release issued April 17, 2026 (In Japanese only):
https://www.anicom-med.co.jp/news/20260417.html
“Hidden Folded-Ear” Phenomenon Identified in Cats
Decline in Genetic Variant Associated with Severe
Osteochondrodysplasia Risk Reported
In a joint study with Anicom Pafe, Inc. and Azabu University, Anicom Specialty
Medical Institute, Inc. confirmed the presence of “hidden folded ears” in some
Scottish Fold cats. The study also demonstrated the importance of genetic testing
for identifying and managing the risk of genetic disorders and improving animal
welfare.
In a joint study with Anicom Pafe, Inc. and Azabu University, Anicom Specialty
Medical Institute, Inc. reported a decline in the prevalence of a genetic variant
associated with a high risk of severe osteochondrodysplasia in Scottish Fold and
other cats.
Press release issued June 1, 2026 (In Japanese only):
https://www.anicom-med.co.jp/news/20260601.html
Press release issued June 8, 2026 (In Japanese only):
https://www.anicom-pafe.com/tands/tands_20260608.html
Copyright © Anicom Holdings, Inc. All Rights Reserved
19
Results
Overview
- Topics (5): Expansion of “JARVIS Tokyo”
Priority
Measures
APPENDIX
“Pet Hotel JARVIS Tokyo” Opened in April
Indoor Dog Park at “Pet Hotel JARVIS Tokyo” Opened to
the Public
“Pet Hotel JARVIS Tokyo” opened in Minato-ku, Tokyo. Located
alongside “JARVIS Animal Medical Center Tokyo,” an advanced and
emergency veterinary care facility, the hotel provides an environment
where owners can leave their dogs with peace of mind.
The indoor dog park adjoining “Pet Hotel JARVIS Tokyo” was opened
to the public. The spacious, open facility, measuring approximately
65 m², allows owners to enjoy spending time with their dogs
regardless of the weather.
Press release issued April 3, 2026 (In Japanese only):
https://www.anicom-sompo.co.jp/news-release/2026/20260403/
Press release issued June 12, 2026 (In Japanese only):
https://www.anicom-sompo.co.jp/news-release/2026/20260612/
Pet-Friendly General Meeting of Shareholders Held at “JARVIS Tokyo”
The General Meeting of Shareholders was held at “JARVIS Tokyo”
(Anicom Building). The event included facility tours and
opportunities to operate a surgical-assist robot, giving
shareholders a firsthand look at our initiatives to realize
“preventive insurance” and at how insurance and veterinary care
work together in practice. In a first for the Company, pets were
permitted at the meeting as part of our efforts to create a General
Meeting of Shareholders that reflects Anicom’s distinctive
character. Several shareholders attended with their dogs.
Copyright © Anicom Holdings, Inc. All Rights Reserved
20
- Topics (6): Capital Policy and Shareholder Returns
Results
Overview
Priority
Measures
APPENDIX
Status of Repurchase of the Company’s Shares
■ Outline
• On May 12, 2026, the Company resolved to conduct a share buyback of up to JPY 1.0 billion.
• The repurchase was scheduled to take place from June 1 to July 31, 2026.
• As of the end of June 2026, approximately JPY 480 million of shares had been repurchased.
(The repurchase of approximately JPY 1.0 billion was completed on July 27, 2026.)
■ Mid-Term Management Plan - Capital Policy Strategy
While maintaining ESR* at an appropriate level, we aim to strike the optimal balance among growth investment,
foundation strengthening, and shareholder returns.
- As of the end of the fiscal year ended March 2026, the ratio was 217.7%, exceeding the 100% threshold regarded as indicating an adequate capacity to pay
insurance claims and other benefits.
Copyright © Anicom Holdings, Inc. All Rights Reserved
21
3
APPENDIX
1. Major Management Indicators
2.
Anicom Insurance (Non-Consolidated): Recurring Revenue Indicators
(Trend in New Policies / Number of Pet Insurance Policies in Force)
3.
Anicom Insurance (Non-Consolidated): Recurring Expenses Indicators
(Loss Ratio (E/I), Expense Ratio based on Earned Premiums)
Results
Overview
- Major Management Indicators
(1) Policies in force
(4) Insurnce payout cases
Vs. previous year-end
Rate
Numbers
1,411,711
93,668
7.1 %
18,939
60,125
-9,690
-13.9 %
260,000
1Q FY03/27
1,318,043
1,392,772
transferred from AXA
Direct)
(3) Renewal rate
Vs. previous year
End-FY03/26
(Including approx. 8,000
266,231
(Including approx. 22,000
APPENDIX
Numbers
1Q FY03/26
69,815
(2) New policies
Priority
Measures
Rate
1.4 %
End-FY03/27
(Forecast)
1,470,000
transferred from AXA Direct)
88.3 %
88.5 %
88.3 %
88.6 %
1,161,000
4,872,000
1,263,000
102,000
8.8 %
5,155,000
End-FY03/27
1Q FY03/26
1Q FY03/27
Vs. previous year
(5) E/I loss ratio
62.4 %
64.5 %
2.1 pt
63.4 %
(6) Expense ratio (based on earned premiums)
35.5 %
31.0 %
-4.5 pt
31.6 %
(7) Combined ratio (based on earned premiums)
97.9 %
95.5 %
-2.4 pt
95.0 %
1Q FY03/26
1Q FY03/27
Vs. previous year
(8) No. of applicants of Doubutsu Kenkatsu
(gut microbiota testing)
62,968
62,985
0.0 %
(9) Animal hospitals accepting Anicom
6,995
7,057
0.9 %
End-FY03/26
1Q FY03/27
Vs. previous year-end
Solvency margin ratio (non-consolidated)
260.9 %
Solvency margin ratio (consolidated)
217.7 %
(Forecast)
[Reference]
- The figure as of the end of the fiscal year ended March 2026 is provided for reference in connection with the transition to the new economic value-based solvency regulation (ESR).
Copyright © Anicom Holdings, Inc. All Rights Reserved
23
- Anicom Insurance (Non-Consolidated):
Recurring Revenue Indicators
Results
Overview
Quarterly trend in number of new policies
Priority
Measures
APPENDIX
Quarterly trend in number of policies in force
(‘000)
(‘000)
Note: Figures include the number of policies transferred from AXA Direct
(from 3Q FY03/25 to 3Q FY03/26).
80
1,392
1,400
69.8
70
66.8
68.6
67.7
55.1
55.4
55.7
54.0
53.9
57.4
1,260
60.1
60.0
59.5
55.2
1,347
1,318
61.3
60
1,411
1,374
1,287
1,213 1,236
1,193
1,200
1,172
57.9
1,132
54.9
1,094
1,049
50
1,154
1,113
1,073
1,000
40
800
30
20
600
10
0
1Q
2Q
3Q
4Q
1Q
23年3月期
FY03/23
系列5
0
0
0
系列4 53.9 55.2 55.4
2Q
3Q
4Q
1Q
24年3月期
FY03/24
0
54
0
0
0
2Q
3Q
4Q
1Q
25年3月期
FY03/25
0
0
0
3
2Q
3Q
4Q
27年
26年3月期
FY03/26
8
8
9
5
55.1 55.7 54.9 57.4 57.9 59.5 58.3 58.8 61.8 59.6 62.2
1Q
FY03/
3月期
27
0
0
60
60.1
400
1Q
2Q
3Q
23年3月期
FY03/23
4Q
1Q
2Q
3Q
24年 3月期
FY03/24
4Q
1Q
2Q
3Q
25年3月期
FY03/25
4Q
1Q
2Q
3Q
26年3月期
FY03/26
4Q
1Q
27年
FY03/
27
3月期
系列1 1,04 1,07 1,09 1113 1132 1154 1172 1193 1213 1236 1260 1287 1318 1347 1374 1392 1411
系列3
系列2
Copyright © Anicom Holdings, Inc. All Rights Reserved
24
- Anicom Insurance (Non-Consolidated):
Recurring Expenses Indicators
[Reference information]
3Q FY03/15
1Q FY03/15
■ Raised premium rate ■ New products with
・Average revision of 12% limited hospital days
■ Launch of “health
discount/extra
premium” system
E/I損害率
E/I loss ratio
70
(%)
60
2Q FY03/18
■ Raised premium rate
・Raised premium rate for
animals that are eight
years or older
3Q FY03/19
■ Launch of “Doubutsu
Kenkatsu”
■ Raised premium rate
• Revised premiums and breed
classes
Results
Overview
59.0
61.6
60.4
60.8
61.1
59.6
APPENDIX
Note 1: The graph below shows quarterly average values, and the data therefore may differ from
average values for current period.
Note 2: The expense ratio represents the “expense ratio based on earned premiums” (insurance
business expenses / earned premiums).
既経過事業費率
Expense ratio
59.9
Priority
Measures
61.7
62.4
62.0
62.7
64.5
63.6
60.0
57.8
57.7
56.3
50
Revision of premiums for “Doubutsu Kenpo
Family” (pet insurance) Wide Type
Transfer of AXA
DIRECT insurance policies
40
35.5
35.1
34.8
34.4
30
35.5
33.8
33.0
33.3
33.0
33.9
33.5
32.8
31.4
31.4
32.6
29.6
31.0
20
1Q
2Q
3Q
23年3月期
FY03/23
4Q
1Q
2Q
3Q
24年3月期
FY03/24
4Q
1Q
2Q
3Q
25年3月期
FY03/25
Copyright © Anicom Holdings, Inc. All Rights Reserved
4Q
1Q
2Q
3Q
26年3月期
FY03/26
4Q
1Q
27年
FY03/
3月期
27
25
(Reference) Impact of insurance accounting on recurring
profits/losses
Results
Overview
Priority
Measures
APPENDIX
- Impact of growth in premium on recurring profits/losses (Based on Japanese non-life insurance accounting)
Generally, the growth in premium contributes to an increase in recurring revenue, but Japanese non-life insurance business laws require non-life insurance
companies to carry any unearned premium portion over to the coming fiscal year as an underwriting reserve (unearned premium). Conversely, expenses such as
claims incurred, agency commissions, operating and general administrative expenses are required to be accounted to that fiscal year. There is, therefore, a negative
impact on recurring profits/losses when above expenses exceed earned premium in current fiscal year even if sales revenue rise due to growth in premium.
Coming fiscal year
Current fiscal year
(Unearned premiums)
(*Earned premiums)
Policies commencing in April
Policies commencing in May
Claims
incurred
Policies commencing in June
Policies commencing in July
Policies commencing in August
Policies commencing in September
Earned
premiums
Policies commencing in October
Policies commencing in March
Agency
commissions
Operating and
general
administrative
expenses
- Impact of catastrophe reserves on recurring profits/losses (Based on Japanese non-life insurance accounting)
・Every non-life insurance company must accumulate catastrophe reserves each fiscal year in order to prepare for natural disasters
・The reserve is liquidated (decreases expenses) when the net loss ratio* exceeds 50%. *Net claims paid ÷ Net premiums written
Copyright © Anicom Holdings, Inc. All Rights Reserved
26